The SERCEB Mouse Monoclonal Antibody Core is housed within the Epitope Recogniton and Immunoreagent Core (ERIC) located at the University of Alabama at Birmingham. The core is responsible for the development and large-scale production of mouse Mabs for use by SERCEB members in studies relating to biodefense and emerging infectious diseases. Services provided by the facility include: procurement and housing of pathogen-free rodents, design and implementation of immunization strategies, sera testing, performance effusions and screening assays, specificity testing, cryopreservation of hybridoma lines, subcloning by limiting dilution, isotyping and large-scale production and purification of Mabs. To be of further service to SERCEB investigators, the core is extending its service to include biotyinylation and enzyme conjugation of Mabs. The Mouse Monoclonal Antibody Core has extensive experience in working with offsite investigators. The core has developed flexible protocols that provide investigators with extended periods of time for screening hybridoma supernatants off campus or in BSL3 facilites if necessary.
The monoclonal antibodies produced in this core facility, will play a crucial role in the detection and characterization of infectious agents that are responsible for human disease. Furthermore, some of the antibodies produced in the core, may provide treatment strategies for infectious agents.
|Guo, Haitao; Gao, Jianmei; Taxman, Debra J et al. (2014) HIV-1 infection induces interleukin-1? production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes. J Biol Chem 289:21716-26|
|Emery, Felicia D; Stabenow, Jennifer M; Miller, Mark A (2014) Efficient inactivation of Burkholderia pseudomallei or Francisella tularensis in infected cells for safe removal from biosafety level 3 containment laboratories. Pathog Dis 71:276-81|
|Rice, Amanda D; Adams, Mathew M; Lindsey, Scott F et al. (2014) Protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease. J Virol 88:7753-63|
|Pop, Laurentiu M; Barman, Stephen; Shao, Chunli et al. (2014) A reevaluation of CD22 expression in human lung cancer. Cancer Res 74:263-71|
|Agnihothram, Sudhakar; Yount Jr, Boyd L; Donaldson, Eric F et al. (2014) A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. MBio 5:e00047-14|
|Zellweger, Raphaël M; Eddy, William E; Tang, William W et al. (2014) CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. J Immunol 193:4117-24|
|Zhao, Jincun; Li, Kun; Wohlford-Lenane, Christine et al. (2014) Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A 111:4970-5|
|Krumm, Stefanie A; Yan, Dan; Hovingh, Elise S et al. (2014) An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci Transl Med 6:232ra52|
|Blake, Lauren E; Garcia-Blanco, Mariano A (2014) Human genetic variation and yellow fever mortality during 19th century U.S. epidemics. MBio 5:e01253-14|
|de Alwis, Ruklanthi; de Silva, Aravinda M (2014) Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based technique. Methods Mol Biol 1138:27-39|
Showing the most recent 10 out of 288 publications